seed
Stage
1
Investors
About
Pulmobiotics is a spin-off from the University of Barcelona and IDIBAPS, developing novel therapies for respiratory diseases. They utilize engineered bacteria to create these new treatments.
Explore Pulmobiotics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.